1+ day, 34+ min ago   (11+ words) Lessons from the defeat of malaria can help us address Lyme...

3+ day, 19+ hour ago   (490+ words) — Excess deaths seen in trial combining the BCL2 inhibitor with intensive initial regimen Adding the BCL2 inhibitor venetoclax (Venclexta) to chemoimmunotherapy led to worse outcomes and excess mortality in patients with newly diagnosed double-hit lymphoma, phase II results from a randomized trial…...

4+ day, 19+ hour ago   (661+ words) — Tozorakimab highly promising as biologic therapy in replicate phase III trials A broad population of people with chronic obstructive pulmonary disease (COPD), current and former smokers alike, experienced fewer exacerbations taking a first-in-class biologic targeting interleukin (IL)-33, a pair of…...

4+ day, 20+ hour ago   (325+ words) — German study focused on cases referred to rheumatologists Analysis of 60 cases from a registry of rheumatologist-treated immune-related adverse events (IRAEs) from ICI treatment revealed that almost one-quarter required hospitalization and 38% had to stop ICIs permanently, according to Didzis Gailis, MD,…...

5+ day ago   (582+ words) Rachael Robertson joined the enterprise and investigative team at MedPage Today in March of 2023. Her print, data, and audio stories have appeared in Everyday Health, Gizmodo, the Bronx Times, and multiple podcasts. Rachael is a member of NLGJA, which awarded…...

5+ day, 1+ hour ago   (491+ words) — The announcement gives the agency some stability following months of controversy The administration of President Donald Trump filled four senior positions at the FDA on Tuesday, promoting several officials who had been serving in acting roles to permanently fill the…...

6+ day, 1+ hour ago   (542+ words) — Analysis offers surprising twist to the smoking-Parkinson's puzzle Non-smokers with higher exhaled carbon monoxide (CO) levels had a lower risk of Parkinson's disease, a prospective study of more than 500,000 people in China showed. Among people who never smoked, exhaled CO…...

1+ week, 2+ day ago   (13+ words) You passed medical training, now see if you can pass our weekly quiz...

1+ week, 2+ day ago   (13+ words) Few details are available on the proposal, which has a 5-day comment period...

1+ week, 3+ day ago   (229+ words) — News, features, and commentary about cancer-related issues The FDA approved ropeginterferon alfa-2b (Besremi) injection to treat adults with essential thrombocythemia, the first new therapy for the chronic blood cancer since the 1997 approval of anagrelide. A national survey showed that almost…...